1JGT : CRYSTAL STRUCTURE OF BETA-LACTAM SYNTHETASE

  • Matthew T. Miller (Contributor)
  • Brian O. Bachmann (Contributor)
  • Craig A. Townsend (Contributor)
  • Amy C Rosenzweig (Contributor)

Dataset

Description

Experimental Technique/Method:X-RAY DIFFRACTION
Resolution:1.95
Classification:HYDROLASE
Release Date:2001-12-28
Deposition Date:2001-06-26
Revision Date:2008-04-27#2011-07-13#2017-10-04
Molecular Weight:111215.15
Macromolecule Type:Protein
Residue Count:1026
Atom Site Count:7567
DOI:10.2210/pdb1jgt/pdb

Abstract:
The enzyme beta-lactam synthetase (beta-LS) catalyzes the formation of the beta-lactam ring in clavulanic acid, a clinically important beta-lactamase inhibitor. Whereas the penicillin beta-lactam ring is generated by isopenicillin N synthase (IPNS) in the presence of ferrous ion and dioxygen, beta-LS uses ATP and Mg2+ as cofactors. According to sequence alignments, beta-LS is homologous to class B asparagine synthetases (AS-Bs), ATP/Mg2+-dependent enzymes that convert aspartic acid to asparagine. Here we report the first crystal structure of a beta-LS. The 1.95 A resolution structure of Streptomyces clavuligerus beta-LS provides a fully resolved view of the active site in which substrate, closely related ATP analog alpha,beta-methyleneadenosine 5'-triphosphate (AMP-CPP) and a single Mg2+ ion are present. A high degree of substrate preorganization is observed. Comparison to Escherichia coli AS-B reveals the evolutionary changes that have taken place in beta-LS that impede interdomain reaction, which is essential in AS-B, and that accommodate beta-lactam formation. The structural data provide the opportunity to alter the synthetic potential of beta-LS, perhaps leading to the creation of new beta-lactamase inhibitors and beta-lactam antibiotics.
Date made available2001
PublisherRCSB-PDB

Cite this